Z-0665-2017 Class II Terminated

Recalled by Merge Healthcare, Inc. — Hartland, WI

FDA device recall Z-0665-2017 was initiated by Merge Healthcare, Inc. on Apr 30, 2014 and is designated Class II. Reason for recall: The application may crash during the cath lab procedure. The recall status is terminated (terminated Dec 23, 2019). Affected quantity: 192 sites potentially have the affected software.

Recall details

Product Type
Devices
Report Date
Dec 7, 2016
Initiation Date
Apr 30, 2014
Termination Date
Dec 23, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
192 sites potentially have the affected software

Product description

Merge Hemo software. Merge Hemo monitors, measures, and records physiologic data from a human patient undergoing a cardiac catheterization procedure. The Monitoring System is for the monitoring of vital parameters including ECG, SpO2, invasive blood pressure, temperature, NIBP and CO2, and for the evaluation of resting ECG, arrhythmias, ST-segments and cardiac output. Some systems are built and designed to measure End Tidal CO2. The system is intended for use in hospital cardiac catheterization laboratories

Reason for recall

The application may crash during the cath lab procedure.

Distribution pattern

Nationwide Distribution

Code information

Versions 9.10, 9.20.0, 9.20.2, 9.30.0, 9.40.0, 9.40.1, and 9.40.2 with Windows 7 Operating System

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0665-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0665-2017. Report a data issue: hello@regdatalab.com.